CEPMED

  • About Cepmed
    • Leadership
    • Press Releases
    • Board of Directors
    • Founding Members
    • Annual Reports
    • Events
  • Cepmed Activities
    • Public-Private Partnerships
    • Commercialization
    • Knowledge Translation
      • Physician Expert Panels
      • National Physician Survey
      • Economic Forum of the Americas 2010
  • About Personalized Medicine
    • Personalized Medicine 101
    • Reports and Articles
    • News and Developments
  • Personalized Medicine Portal
    • For Cancer
    • For Other Conditions
    • For Medication
    • Tests A-Z
  • Home
  • Contact Us
  • Français
  • Print
  • Share
    • del.icio.us del.icio.us
    • StumbleUpon StumbleUpon
    • digg digg
    • Twitter Twitter
    • Facebook Facebook
    • Google Google
    • Linked In Linked In
  • Send

News and Developments

February 16, 2012

Le premier et seul traitement personnalisé pour la forme la plus mortelle de cancer de la peau approuvé par Santé Canada

February 16, 2012

First and Only Personalized Treatment for Deadliest Form of Skin Cancer Approved by Health Canada

January 31, 2012

Harper Government Invests In Personalized Medicine

January 16, 2012

U.K. Counts on New Strategy to Push Biopharma Startups Past “Valley of Death”

January 13, 2012

Same day genomes, two new sequencing machines will read a human genome in 24 hours

January 12, 2012

Financial returns: The missing link in personalized medicine

January 10, 2012

Not Quite The $1,000 Genome, But Maybe Close Enough

January 8, 2012

This time, it’s personal

January 2, 2012

What we should learn from our pathology problems

January 1, 2012

Latest News & Updates from the Personalized Medicine Coalition

Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Next

Copyright © 2010 - 2012 CEPMED    Terms & Conditions • Site Map